Table 1.
General Organization and Clinical Characteristics for Genetic Cerebral Arteriopathies
| Clinical characteristics | Diagnostic consideration | ||||
| Noninflammatory CSF | Aortopathy | Cerebral aneurysms more prominent | Renal cysts or renal failure | ADPKD | |
| Cerebral AVMs, characteristic 'velvet’ skin | vEDS | ||||
| Bifid uvula | Loeys-Dietz | ||||
| Cerebral aneurysms less prominent | Moyamoya phenomenon | MYH11-related or ACTA2-related disorders | |||
| Marfanoid appearance, ectopia lentis | Marfan syndrome | ||||
| Prominent arterial tortuosity | SLC2A10 arterial tortuosity syndrome | ||||
| No aortopathy | Cerebral small vessel disease | Claudication, peripheral neuropathy, painful crises | Nephropathy | Fabry disease | |
| Sagging skin, hyperpigmentation | Pseudoxanthoma elasticum | ||||
| No claudication, peripheral neuropathy, painful crises | Cognitive changes, headaches, mood disorder | CADASIL | |||
| Cognitive changes, resistant hypertension, cerebral hemorrhage, migraines | CARASAL | ||||
| Spastic diplegia, alopecia | CARASIL | ||||
| Pontine predominance | PADMAL | ||||
| Livedo reticularis | Deficiency of ADA2 | ||||
| Minimal cerebral small vessel disease or prominent intracerebral hemorrhage | Cerebral AVMs | Prominent telangiectasias | HHT | ||
| Hemorrhage, migraines | COL4A1-related disorders | ||||
| Moyamoya phenomenon | Skin findings, optic glioma | NF1 | |||
| Systemic findings (splenic infarcts, sickle cell, Down syndrome), radiation vasculopathy, progressive intracranial atherosclerosis) | Secondary moyamoya | ||||
| Primary Moyamoya | RNF213-related disorder | ||||
| Neither cerebral AVMs nor moyamoya phenomenon | Prominent pial angiomas | Sturge-Weber | |||
| Aneurysms, muscular weakness | Pompe disease | ||||
| Hemorrhage, dementia | Hereditary cerebral amyloid angiopathy | ||||
| Inflammatory CSF | Leukoencephalopathy, retinal vasculitis, nephropathy | TREX1-related RVCL | |||
| Encephalopathy, seizures, young age | Aicardi-Goutières | ||||
Abbreviations: ADPKD = autosomal dominant polycystic kidney disease; AVM = arteriovenous malformation; CADASIL = cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy; CARASAL = cathepsin A–related arteriopathy with strokes and leukoencephalopathy; CARASIL = cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy; HHT = hereditary hemorrhagic telangiectasia; NF1 = neurofibromatosis type 1; PADMAL = pontine autosomal dominant microangiopathy and leukoencephalopathy; vEDS = vascular Ehlers-Danlos disease.